Kotaniemi-Talonen L - Search Results

1

Overtreatment rate after immediate local excision of suspected cervical intraepithelial neoplasia: A prospective cohort study.

Kiviharju M, Heinonen A, Jakobsson M, Virtanen S, Auvinen E, Kotaniemi-Talonen L, Dillner J, Kyrgiou M, Nieminen P, Aro K, Kalliala I. Kiviharju M, et al. Gynecol Oncol. 2022 Nov;167(2):167-173. doi: 10.1016/j.ygyno.2022.09.016. Epub 2022 Sep 22. Gynecol Oncol. 2022. PMID: 36153296 Free article.

2

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.

Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M. Kotaniemi-Talonen L, et al. Br J Cancer. 2005 Oct 17;93(8):862-7. doi: 10.1038/sj.bjc.6602799. Br J Cancer. 2005. PMID: 16189520 Free PMC article. Clinical Trial.

3

Alternative technologies in cervical cancer screening: a randomised evaluation trial.

Anttila A, Hakama M, Kotaniemi-Talonen L, Nieminen P. Anttila A, et al. BMC Public Health. 2006 Oct 16;6:252. doi: 10.1186/1471-2458-6-252. BMC Public Health. 2006. PMID: 17042938 Free PMC article.

4

Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland.

Kotaniemi-Talonen L, Nieminen P, Hakama M, Seppänen J, Ikkala J, Martikainen J, Tarkkanen J, Toivonen T, Anttila A. Kotaniemi-Talonen L, et al. Eur J Cancer. 2007 Jan;43(1):169-74. doi: 10.1016/j.ejca.2006.08.026. Epub 2006 Oct 16. Eur J Cancer. 2007. PMID: 17049228

5

Randomized evaluation trial on automation-assisted screening for cervical cancer: results after 777,000 invitations.

Nieminen P, Kotaniemi-Talonen L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, Ikkala J, Anttila A. Nieminen P, et al. J Med Screen. 2007;14(1):23-8. doi: 10.1258/096914107780154468. J Med Screen. 2007. PMID: 17362568 Clinical Trial.

6

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3.

Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, Nieminen P. Kotaniemi-Talonen L, et al. Eur J Cancer. 2008 Mar;44(4):565-71. doi: 10.1016/j.ejca.2007.12.002. Epub 2008 Jan 8. Eur J Cancer. 2008. PMID: 18248809 Clinical Trial.

7

Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland.

Leinonen M, Kotaniemi-Talonen L, Anttila A, Dyba T, Tarkkanen J, Nieminen P. Leinonen M, et al. Int J Cancer. 2008 Sep 15;123(6):1344-9. doi: 10.1002/ijc.23670. Int J Cancer. 2008. PMID: 18566992

8

Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.

Kotaniemi-Talonen L, Malila N, Nieminen P, Anttila A, Tarkkanen J, Laurila P, Hakama M. Kotaniemi-Talonen L, et al. Int J Cancer. 2008 Dec 15;123(12):2902-6. doi: 10.1002/ijc.23839. Int J Cancer. 2008. PMID: 18792100 Clinical Trial.

9

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. Leinonen M, et al. J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9. J Natl Cancer Inst. 2009. PMID: 19903804 Clinical Trial.

10

Low proportion of false-negative smears in the Finnish program for cervical cancer screening.

Lönnberg S, Anttila A, Kotaniemi-Talonen L, Kujari H, Melkko J, Granroth G, Vornanen M, Pietiläinen T, Sankila A, Arola J, Luostarinen T, Nieminen P. Lönnberg S, et al. Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):381-7. doi: 10.1158/1055-9965.EPI-09-1038. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20142239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters